CDS research Blog

What do D-dimer values and ferritin indicate about the condition of the body?

D-dimer values and ferritin levels are important biomarkers that can provide significant insights into the condition of the body.

D-dimer is a small protein fragment that is present in the blood after a blood clot dissolves. Elevated levels of D-dimer can indicate that there is an increased amount of clot formation and breakdown in the body, which may suggest conditions such as deep vein thrombosis (DVT), pulmonary embolism, or disseminated intravascular coagulation (DIC). However, elevated D-dimer levels can also be seen in other situations such as infection, inflammation, or recent surgery, so they must be interpreted in conjunction with clinical findings and other diagnostic tests.

Ferritin, on the other hand, is a protein that stores iron in the body and releases it in a controlled fashion, playing a crucial role in iron metabolism. Low ferritin levels typically indicate low iron stores, which can lead to iron deficiency anemia, causing symptoms like fatigue, weakness, and shortness of breath. Conversely, high ferritin levels may indicate an excess of iron in the body or inflammation, as ferritin is an acute-phase reactant that can increase in response to inflammatory conditions or infections.

Together, D-dimer and ferritin levels can provide valuable information regarding clotting status and iron metabolism, helping healthcare providers assess and manage various medical conditions effectively.

Link

Known types list of Cancer

There are several known types of cancer that affect different parts of the body. Each type has its own characteristics and treatment options. Some of the most common types include breast cancer, lung cancer, prostate cancer, colorectal cancer, skin cancer, and leukemia. Additionally, there are other less common types such as pancreatic cancer, ovarian cancer, liver cancer, and kidney cancer. Each of these cancers can vary significantly in their symptoms, risk factors, and prognosis. Understanding the specific type of cancer is crucial for determining the most effective treatment strategies and improving patient outcomes.

Link

Efficacy list of ClO₂ against known Pathogens

The efficacy of chlorine dioxide (ClO2) against known pathogens has been studied extensively in various settings, demonstrating its effectiveness as a powerful antimicrobial agent. Research indicates that ClO2 is capable of inactivating a wide range of bacteria, viruses, and fungi. This includes common pathogens such as Escherichia coli, Salmonella spp., Listeria monocytogenes, and Staphylococcus aureus, among others.

In addition to its bactericidal properties, ClO2 has shown significant antiviral activity against viruses such as influenza and norovirus, making it an important consideration for infection control in both healthcare and food processing environments. Studies have consistently illustrated that ClO2 operates effectively over a range of concentrations and exposure times, allowing for versatility in its application.

Furthermore, the mode of action of chlorine dioxide involves the disruption of cellular processes and the oxidation of essential biomolecules, which contributes to its broad-spectrum efficacy. As a result, ClO2 is being increasingly utilized in various disinfection protocols, especially in areas where controlling pathogens is crucial for public health and safety.

Link

Report on CDS by Dr. Luis Prieto Valiente, PhD, is a professor at UCAM (Catholic University of Murcia) using Chlorine Dioxide as an “unproven intervention”

Report by Dr. Luis Prieto Valiente, PhD, an esteemed professor of Statistical Analysis and Research Methodology, regarding the significance, or lack thereof, of employing Chlorine Dioxide as an “unproven intervention” in the treatment of COVID-19 infections. This report aims to critically evaluate the existing evidence surrounding the use of Chlorine Dioxide, assessing its potential benefits and drawbacks in the context of the ongoing pandemic. The analysis will explore various studies, clinical trials, and expert opinions to determine whether this substance should be considered a viable option for patients suffering from COVID-19 or if it poses more risks than advantages.